扶桑薬品工業株式会社
Fuso Pharmaceutical Industries,Ltd. is a listed company. Its directors and officers file their transactions with EDINET (Japan FSA). 2 insiders have disclosed 4 filings since 18 October 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
There has been no open-market purchase by an insider of Fuso Pharmaceutical Industries,Ltd. for at least a year. Typically, a trade is published a median of 7 days after it takes place. That lag is the time during which only the insider knows about the trade.
With 4 filings in twelve months, the company is more active than the median of 3 filings across the 3,419 companies we follow on the same exchange.
Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
13 of 13 declarations
Fuso Pharmaceutical Industries, Ltd. is a Japanese company specializing in the manufacture of pharmaceutical products. It is listed on the XTKS market.